Discovery of Potent Thermolysin Inhibitors Using Structure Based Virtual Screening and Binding Assays

Journal of Medicinal Chemistry
2009.0

Abstract

In the present work, 22 compounds of the U.S. NCI compound library (size 273K) were identified as putative thermolysin binders by structure based virtual screening with the ICM software (ICM-VLS). In vitro competitive binding assays confirmed that 12 were thermolysin binders. Thermolysin binding modes of the 12 compounds were studied by docking using ICM and Molegro Virtual Docker (MVD). The most potent inhibitor had an IC(50) value of 6.4 x 10(-8) mM (NSC250686, 1 beta-D-arabinofuranosyl-N(4)-lauroylcytosine). The structure of this compound is quite different from the other 11 compounds. Nine out of the 12 compounds contained a similar chemical skeleton (3-nitrobenzamide derivatives) and have IC(50) values ranging from 697.48 to 0.047 mM. The ICM-VLS score and the activity profiles (pIC(50) values) were compared and found to be somewhat linearly correlated (R(2) = 0.78). Kinetic studies showed that, except for NSC285166 (oxyquinoline), the compounds are competitive thermolysin inhibitors.

Knowledge Graph

Similar Paper

Discovery of Potent Thermolysin Inhibitors Using Structure Based Virtual Screening and Binding Assays
Journal of Medicinal Chemistry 2009.0
Identification of novel quinazolin-4(3H)-ones as inhibitors of thermolysin, the prototype of the M4 family of proteinases
Bioorganic & Medicinal Chemistry 2010.0
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening
European Journal of Medicinal Chemistry 2016.0
Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening
Bioorganic & Medicinal Chemistry Letters 2013.0
Development of NMR and thermal shift assays for the evaluation ofMycobacterium tuberculosisisocitrate lyase inhibitors
MedChemComm 2017.0
A novel aminopeptidase N inhibitor developed by virtual screening approach
Bioorganic & Medicinal Chemistry Letters 2012.0
Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening
Bioorganic & Medicinal Chemistry Letters 2008.0
Identification of compounds exhibiting inhibitory activity toward the Pseudomonas tolaasii toxin tolaasin I using in silico docking calculations, NMR binding assays, and in vitro hemolytic activity assays
Bioorganic & Medicinal Chemistry Letters 2009.0
A THERMOLYSIN INHIBITOR PRODUCED BY ACTINOMYCETES: PHOSPHORAMIDON
The Journal of Antibiotics 1973.0
IKKβ inhibitors identification part I: Homology model assisted structure based virtual screening
Bioorganic & Medicinal Chemistry 2009.0